Trials / Completed
CompletedNCT00292929
Study of the Safety of Intravenous Artesunate
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Single Intravenous Doses of Artesunate Administered to Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- U.S. Army Medical Research and Development Command · Federal
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to establish the safety, tolerability and pharmacokinetics of a single dose of the antimalarial drug artesunate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravenous artesunate |
Timeline
- Completion
- 2006-10-01
- First posted
- 2006-02-16
- Last updated
- 2016-10-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00292929. Inclusion in this directory is not an endorsement.